Generally Good Indian Pharma Companies

If someone is buying from India, I would suggest targeting medications from only the largest of the Pharma companies (i.e. top 15 or so companies). There are many smaller pharma companies, that don’t adhere to international quality standards it seems.

Here is a list I found that may be helpful in this quest (Source here)

In this article, we will explore the Top 20 Pharmaceutical Companies in India and their contributions to the industry.

COMPANY NAME FOUNDING YEAR FOUNDER HEADQUARTERS VALUATION REVENUE 2022 (CONSOLIDATED) REVENUE (STANDALONE) ACQUISITIONS IPO STATUS
Sun Pharmaceutical Industries 1983 Dilip Shanghvi Goregaon, Mumbai $26.2 Billion $4.95 Billion $2.07 Billion 12 Public
Divi’s Laboratories 1990 Murali Divi Hyderabad $12.6 Billion $1.13 Billion $1.1 Billion 0 Public
Dr. Reddy’s Laboratories 1984 Dr. Kallam Anji Reddy Hyderabad $9.1 Billion $2.7 Billion $1.8 Billion 6 Public
Cipla Limited 1935 Khwaja Abdul Hamied Mumbai $9.8 Billion $2.7 Billion $1.7 Billion 6 Public
Emcure Pharmaceuticals 1983 Satish Ramanlal Mehta Pune $0.63 Billion $762.8 Million - 4 Registered
Biocon Limited 1978 Kiran Mazumdar-Shaw Bengaluru $4.9 BIllion $1.05 Billion $241 Million 1 Public
Torrent Pharma 1959 U. N. Mehta Ahmedabad $6.2 Billion $1.09 Billion $869.9 Million 5 Public
Lupin Limited 1968 Desh Bandhu Gupta Mumbai $3.6 Billion $2.07 Billion $1.4 Billion 9 Public
Zydus Lifesciences Limited (formerly Cadila Healthcare) 1952 Ramanbhai Patel Ahmedabad $4.4 Billion $1.9 Billion $1.02 Billion 4 Public
Aurobindo Pharma Limited 1986 P. V. Ramaprasad Reddy and K. Nityananda Reddy Hyderabad $4.04 Billion $2.9 Billion $1.4 Billion 7 Public
Intas Pharmaceuticals Limited 1976 Hasmukh Chudgar Ahmedabad $4.3 Billion $2.2 Billion - 2 Private
Glenmark Pharma Limited 1977 Gracias Saldanha Mumbai $1.3 Billion $1.5 Billion $1.09 Billion 4 Public
Mankind Pharma Limited 1995 R. C. Juneja and Rajeev Juneja New Delhi $1 Billion - 1 Private
Piramal Enterprises Limited 1984 Ajay Piramal Mumbai $5.5 Billion $1.8 Billion $337.3 Million 7 Public
Laurus Labs Ltd. 2005 Dr. Satyanarayana Chava Hyderabad $3.4 Billion $619.8 Million $591.1 Million 1 Public
Abbott India Ltd. 1944 Dr Wallace Calvin Abbott Mumbai $5.3 Billion - $625.7 Million 1 Public
Alkem Laboratories 1973 Samprada Singh Mumbai $4.7 Billion $1.3 Billion $1.1 Billion 3 Public
Alembic Pharmaceuticals 1907 Prof. T. K. Gajjar, Prof. A. S. Kotibhasker, B. D. Amin Vadodara $1.7 Billion $670.8 Million $632 Million 2 Public
Innovexia Life Sciences Pvt. Ltd. 2011 Sandeep Khajuria Chandigarh - $14.3 Million - - Private
Biophar Lifesciences Pvt. Ltd. 2010 Gulshan Rawat Chandigarh - - - - Private

Top 20 Pharmaceutical Companies of India

  1. Sun Pharmaceutical Industries
  2. Divi’s Laboratories
  3. Dr. Reddy’s Laboratories
  4. Cipla Limited
  5. Emcure Pharmaceuticals
  6. Biocon Limited
  7. Torrent Pharma
  8. Lupin Limited
  9. Zydus Lifesciences Limited (formerly Cadila Healthcare)
  10. Aurobindo Pharma Limited
  11. Intas Pharmaceuticals Limited
  12. Glenmark Pharma Limited
  13. Innovexia Life Sciences Pvt. Ltd.
  14. Biophar Lifesciences Pvt.Ltd.
  15. Mankind Pharma Limited
  16. Piramal Enterprises Limited
  17. Laurus Labs Ltd.
  18. Abbott India Ltd.
  19. Alkem Laboratories
  20. Alembic Pharmaceuticals
5 Likes

In this list I would only buy from companies that also sell in Europe and the US. Higher standards.

6 Likes

Yes - that is probably a good idea, but it takes a little more research to figure out those companies that do sell to Western Europe and USA. I’d guess that its these from the top of my head, but if anyone knows better, please post:

  1. Sun Pharmaceutical Industries
  2. Dr. Reddy’s Laboratories
  3. Cipla Limited
  4. Biocon Limited
  5. Zydus Lifesciences Limited (formerly Cadila Healthcare)
  6. Intas Pharmaceuticals Limited
  7. Glenmark Pharma Limited
  8. Abbott India Ltd.
7 Likes

Lupin is also massive in the US: Lupin Limited - Wikipedia

And Aurobindo has apparently a strong presence in the US and Europe: https://www.fiercepharma.com/pharma/top-10-generic-drugmakers-2021-revenue

Also, with the exception of Intas, which is private, all the above companies are traded on the New York Stock Exchange. So they have the constant scrutiny of the markets.

1 Like

I notice rapacan rapamycin product is made by both Biocon and Eris. Anyone have experience or lab tests with the version made by Eris?

2 Likes

No - Eris is just a marketing company, its still made by the same company Swiss Garnier. See this thread and post: Eris LifeSciences Brand of Sirolimus from India - #6 by KoolieDude17

2 Likes

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI). By 2024, despite a tightening of regulatory standards, the number of inspections dropped to 206, while OAI cases fell to 14 and VAI cases reduced to 115. This highlights that the sector is increasingly aligning with global benchmarks to ensure high-quality manufacturing practices.

https://www.business-standard.com/health/indian-pharma-improves-compliance-with-usfda-fewer-oai-cases-in-2024-124122900413_1.html

2 Likes

Yes… but. The FDA currently has to give advanced notice of inspections to the Indian Pharma… and there have been many situations where Indian Pharma has been caught (insiders reveal) changing / modifying things to make them look better during the inspection… so I’m not super confident that things are that much better.

2 Likes